UK’s MHRA approves Viagra Connect OTC switch

29 November 2017 - Deborah Wilkes

Archived

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has switched Pfizer’s erectile-dysfunction drug Viagra (sildenafil) from prescription to non-prescription status following a public consultation. Pfizer said it was “working on plans for the launch of Viagra Connect in the UK in the spring of 2018”.

Click tags below for more information on topics:

MHRA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: